# A Randomized, Double-Blind, Placebo-Controlled Study of Droxidopa for Fatigue in Parkinson's Disease

> **NCT03034564** · PHASE4 · TERMINATED · sponsor: **The Cooper Health System** · enrollment: 1 (actual)

## Conditions studied

- Parkinson Disease
- Fatigue
- Parkinsonism

## Interventions

- **DRUG:** Northera
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03034564
- **Lead sponsor:** The Cooper Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-01
- **Primary completion:** 2018-09-30
- **Final completion:** 2018-09-30
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Site staffing
- **Last updated:** 2021-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03034564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03034564, "A Randomized, Double-Blind, Placebo-Controlled Study of Droxidopa for Fatigue in Parkinson's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03034564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*